APAC Genetic Testing Market Analysis - Size and Forecast 2024-2028

APAC Genetic Testing Market Size 2024-2028 

The APAC genetic testing market size is forecast to increase by USD 2.49 billion, at a CAGR of 17.8% between 2023 and 2028.

• In the APAC genetic testing market, the approval of advanced genetic testing products is gaining momentum, driven by the increasing awareness and acceptance of personalized healthcare. This trend is further fueled by the rapid advancements in next-generation sequencing technology, enabling faster and more accurate genetic testing. Bioinformatics tools and digital health platforms are essential components of the market, facilitating data analysis and interpretation and enabling easy access to electronic health records. However, the market landscape is complex, with varying regulations on genetic testing and research across different countries posing significant challenges. Navigating these regulatory hurdles requires a deep understanding of local laws and regulations, making it essential for companies to establish strong partnerships with local regulatory bodies and experts.
• Effective collaboration and compliance with these regulations will be crucial for market success, as companies seek to capitalize on the significant growth opportunities in the APAC genetic testing market.

What will be the size of the APAC Genetic Testing Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.  
 Request Free Sample

• In the Asian Pacific (APAC) market, genetic testing has emerged as a critical tool for disease diagnosis, with molecular diagnostics and gene expression profiling gaining traction. Ethical guidelines are strictly adhered to ensure patient privacy and informed consent. Single nucleotide polymorphisms (SNPs) and copy number variations (CNVs) serve as essential genetic markers for diagnosing various diseases. Regulatory compliance, data security, and data integrity are top priorities, with laboratories implementing robust data management systems and automation technology to enhance throughput capacity and improve diagnostic accuracy. Result reporting is streamlined, ensuring test specificity and sensitivity meet clinical utility standards. Negative predictive value is equally important, with chromosome analysis and protein biomarkers playing significant roles.
• Quality control measures are implemented rigorously to maintain diagnostic accuracy, while sample tracking and test result reporting ensure efficient laboratory workflow. Patient consent is obtained through standardized procedures, and data management systems ensure data security and privacy. Regulatory bodies continue to emphasize regulatory compliance, and ethical guidelines are being updated to address emerging trends in genetic testing.

How is this market segmented?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Application
  • Cancer diagnosis
  • Genetic disease diagnosis
  • Cardiovascular disease diagnosis
  • Others
• Product
  • Equipment
  • Consumables
• Geography
  • APAC
    • China
    • India
    • Japan
    • South Korea

By Application Insights

The cancer diagnosis segment is estimated to witness significant growth during the forecast period.

The market is experiencing significant growth due to the increasing demand for early disease diagnosis and personalized medicine. Non-invasive prenatal testing and prenatal diagnosis are key areas of focus, with advancements in sample preparation techniques, such as DNA extraction methods and mutation screening, driving innovation. Quality assurance and laboratory accreditation are crucial for ensuring accuracy and reliability, while ethical considerations and data privacy remain essential concerns. Advancements in genome sequencing technologies, including whole genome sequencing and next-generation sequencing, have led to the development of predictive testing and carrier screening. Digital PCR and quantitative PCR are also gaining popularity for their accuracy and efficiency.

Cytogenetic analysis and genetic variant detection are other important techniques used in genetic testing. Personalized medicine and disease risk prediction are major trends, with companies investing in bioinformatics pipelines and data interpretation to provide accurate and actionable results. Regulatory frameworks and genetic testing regulation are evolving to ensure standardization and quality. The market is witnessing a surge in the development of advanced genetic testing devices, including polymerase chain reaction, SNP genotyping, and DNA microarray. Newborn screening and STR profiling are also important applications. In conclusion, the market is dynamic and evolving, driven by advancements in technology, increasing demand for personalized medicine, and regulatory frameworks.

Download Free Sample Report

The Cancer diagnosis segment was valued at  USD 396.00 million in 2018 and showed a gradual increase during the forecast period.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the APAC Genetic Testing Market drivers leading to the rise in adoption of the Industry?

• The significant rise in approval for advanced genetic testing products serves as the primary catalyst for market growth. 

• The market is witnessing significant growth due to the increasing adoption of genetic screening in human health management and advancements in whole genome sequencing technology. Despite regulatory complexities and variations, authorities are addressing these challenges to facilitate market entry for companies. Technologically innovative products, such as pharmacogenomics and companion diagnostics, are ensuring product safety and compliance. Furthermore, the introduction of automated and advanced systems is driving market growth.
• Clinical interpretation, non-invasive prenatal testing, prenatal diagnosis, disease risk prediction, and personalized medicine are key application areas. Sample preparation techniques and DNA extraction methods are essential components of these innovative genetic testing solutions. Ensuring data privacy remains a critical concern for companies and regulatory bodies alike.

What are the APAC Genetic Testing Market trends shaping the Industry?

• Next-generation sequencing is currently experiencing significant advancements, making it a prominent market trend in the scientific community. This technology, which enables the massively parallel sequencing of DNA and RNA, is revolutionizing various fields, including genetics and personalized medicine.

• The Human Genome Project's significant advancements and the emergence of next-generation genetic testing technologies have revolutionized the market. These innovations have allowed companies to comprehensively map the human genome and comprehend genetic structures and functionalities related to various disorders. Next-generation sequencing (NGS) has been a game-changer, enabling large-scale human genome sequencing to identify mutations and gene variants that cause diseases. Furthermore, NGS has substantially decreased the cost of sequencing, genomic analysis, and genomic database management, leading to a paradigm shift in the market. Quality assurance measures, such as variant annotation, quantitative PCR, and cytogenetic analysis, ensure accurate results in genetic testing.
• Genome sequencing laboratories undergo rigorous accreditation processes to maintain high-quality standards. Genetic counseling plays a crucial role in interpreting test results and providing patients with appropriate guidance. NGS technologies facilitate mutation screening, enabling the detection of genetic disorders at their earliest stages. The integration of these advanced technologies in the market has led to enhanced diagnostic capabilities and improved patient outcomes.

How does APAC Genetic Testing Market face challenges during its growth?

• The genetic testing and research industry faces significant growth impediments due to the varying regulatory frameworks governing these fields. 

• In the APAC genetic testing market, regulatory compliance is a significant challenge for companies due to varying standards and complex regulations. Genetic testing results play a crucial role in healthcare decision-making for critical health conditions, necessitating high accuracy, safety, and reliability. Regulatory bodies such as the Australia Therapeutic Goods Administration (ATGA), WHO, International Organization for Standardization (ISO), and China Food and Drug Administration (CFDA) enforce stringent regulations on genetic testing products to ensure quality and safety. Compliance with these regulations is essential for market companies to maintain trust and confidence among their customers.
• Technologies like whole genome sequencing, digital PCR, next-generation sequencing, exome sequencing, SNP genotyping, and genetic variant detection are driving the market's growth. Ethical considerations are also essential in genetic testing, and market companies must prioritize transparency and patient privacy.

Exclusive APAC Genetic Testing Market Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, market forecast partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• Agilent Technologies Inc.
• BGI Genomics Co. Ltd.
• Bio Rad Laboratories Inc.
• Danaher Corp.
• Exact Sciences Corp.
• F. Hoffmann La Roche Ltd.
• Genea Ltd.
• Illumina Inc.
• Invitae Corp.
• Mapmygenome India Ltd.
• Myriad Genetics Inc.
• Natera Inc.
• Oxford Gene Technology Group
• Perkin Elmer Inc.
• QIAGEN N.V.
• SciGene Corp.
• The Cooper Companies Inc.
• Thermo Fisher Scientific Inc.
• Yikon Genomics Co. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Genetic Testing Market In APAC

• In January 2024, Illumina, a leading genetic testing solutions provider, announced the launch of its new NextSeq 550Dx System, designed for laboratories in the APAC region to offer cost-effective and rapid genetic testing solutions for infectious diseases and inherited disorders (Illumina Press Release).
• In March 2024, Thermo Fisher Scientific and F.H. Pascoe (M) Sdn Bhd, a Malaysian diagnostics company, entered into a strategic partnership to expand Thermo Fisher's genetic testing offerings in the APAC market, particularly in Malaysia (Thermo Fisher Scientific Press Release).
• In May 2024, Sequenom Inc., a genetic testing company, raised approximately USD 50 million in a funding round to support the expansion of its operations in the APAC region and invest in research and development (Sequenom Press Release).
• In April 2025, the Chinese government announced the launch of a national genetic testing program, "Genome China 2030," aiming to sequence one million genomes and provide genetic testing services to 100 million people by 2030 (Xinhua News Agency).

Research Analyst Overview

The market is characterized by its continuous evolution and dynamic nature, driven by advancements in technology and expanding applications across various sectors. Entities such as mutation screening, quality assurance, variant annotation, genome sequencing, quantitative PCR, genetic counseling, laboratory accreditation, and cytogenetic analysis are integral components of this landscape. Mutation screening and quality assurance ensure the accuracy and reliability of test results, while variant annotation and genome sequencing provide valuable insights into genetic variations and their implications. Quantitative PCR and genetic counseling facilitate the diagnosis and management of genetic conditions, and laboratory accreditation and cytogenetic analysis ensure the highest standards of testing and analysis.

The integration of digital PCR, whole genome sequencing, and next-generation sequencing technologies has expanded the scope of genetic testing, enabling non-invasive prenatal testing, disease risk prediction, and personalized medicine. Sample preparation techniques, DNA extraction methods, and bioinformatics pipelines are essential for efficient and accurate data interpretation. Ethical considerations, data privacy, and genetic testing regulation are crucial aspects of this market, shaping the development and implementation of testing technologies and services. Carrier screening, predictive testing, and newborn screening are some of the applications that continue to unfold, reflecting the ongoing evolution of the market.

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Genetic Testing Market in APAC insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across APAC
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements Get in touch